3 ms·
It's not a general vaccine , but a tailored one aimed at people being treated for cancers that have a high risk of it coming back. So it's not something that ca
by lawlessone 3y ago
It's not a general vaccine , but a tailored one aimed at people being treated for cancers that have a high risk of it coming back. So it's not something that can just be handed out to everyone.
I agree though if a general vaccine is created.
I'm really looking forward to a future where this and heart disease or just merely annoying.
- kurthr 3y agoIn particular: The vaccine works by instructing the body to make up to 34 “neoantigens.” These are proteins found only on the cancer cells, and Moderna personalizes the vaccine for each recipient so that it carries instructions for the neoantigens on their cancer cells.
- loceng 3y agoAnd let me guess - there's a massive lobbying effort to be able to patent each of these neoantigens, if they're not already getting patents approved for them? Edit: Ah yes, why patent specifics when you can patent the umbrella which is akin to covering all bases - https://patents.google.com/patent/US10055540B2/en https://patents.google.com/patent/US10055540B2/en
- blackbear_ 3y agoVery unlikely, as the majority of those neoantigens are unique to the patient (that's why the vaccine has to be tailored for each of them).
- loceng 3y agoAh yes, why patent specifics when you can patent the umbrella which is akin to covering all bases - https://patents.google.com/patent/US10055540B2/en https://patents.google.com/patent/US10055540B2/en
- blackbear_ 3y agoI'm not sure that patent is worth much to be honest. The general approach has been known and published in research circles for the better part of a decade before the patent was filed, and actually training a machine learning system in that way that gives usable predictions is still an open problem afaik.
- loceng 3y ago[flagged]